Effectiveness and safety of 6-months¿ treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study. Conference Poster 2022 Congress communication uri icon

authors

  • Bertoletti L
  • Díaz-Peromingo JA
  • Fidalgo A
  • Gómez-Cuervo C
  • HERNANDEZ BLASCO, LUIS MANUEL
  • López Muñoz JJ
  • López-Miguel P
  • Mellado M
  • Monreal M
  • RIETE Investigators
  • Soler S
  • Tiberio G

publication date

  • 2022